Article
Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Jul 2020
Schwefel Konrad, Spiegler Stefanie, Kirchmaier Bettina C, Dellweg Patricia K E, Much Christiane D, Pané-Farré Jan, Strom Tim M, Riedel Katharina, Felbor Ute, Rath Matthias
Abstract excerpt
Loss-of-function variants in CCM1/KRIT1, CCM2, and CCM3/PDCD10 are associated with autosomal dominant cerebral cavernous malformations (CCMs). CRISPR/Cas9-mediated CCM3 inactivation in human endothelial cells (ECs) has been shown to induce profound defects in cell-cell interaction as well as actin cytoskeleton organization. We here show that CCM3 inactivation impairs fibronectin expression and consequently leads...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
